{"id":"https://openalex.org/W2129012981","doi":"https://doi.org/10.1212/01.wnl.0000166049.51502.6a","title":"Appearance and disappearance of neutralizing antibodies during interferon-beta therapy","display_name":"Appearance and disappearance of neutralizing antibodies during interferon-beta therapy","alternate_titles":[],"publication_year":2005,"publication_date":"2005-07-12","ids":{"openalex":"https://openalex.org/W2129012981","doi":"https://doi.org/10.1212/01.wnl.0000166049.51502.6a","mag":"2129012981","pmid":"https://pubmed.ncbi.nlm.nih.gov/15888603"},"language":"en","primary_location":{"id":"doi:10.1212/01.wnl.0000166049.51502.6a","doi":"https://doi.org/10.1212/01.wnl.0000166049.51502.6a","is_oa":false,"landing_page_url":"https://doi.org/10.1212/01.wnl.0000166049.51502.6a","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2129012981"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066796645","display_name":"Per Soelberg S\u00f8rensen","orcid":"https://orcid.org/0000-0002-2818-3780","observed_orcids":["https://orcid.org/0000-0002-2818-3780"]},"institutions":[{"id":"https://openalex.org/I2799976261","display_name":"Aalborg University Hospital","ror":"https://ror.org/02jk5qe80","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2799976261"]},{"id":"https://openalex.org/I2802567020","display_name":"Copenhagen University Hospital","ror":"https://ror.org/05bpbnx46","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802567020"]},{"id":"https://openalex.org/I2802709434","display_name":"Rigshospitalet","ror":"https://ror.org/03mchdq19","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802567020","https://openalex.org/I2802709434","https://openalex.org/I4210145385"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"P. Soelberg Sorensen","raw_affiliation_strings":["From the Copenhagen MS Center, Department of Neurology (Dr. Sorensen), and Institute for Inflammation Research (Drs. Ross and Bendtzen), Copenhagen University Hospital, Rigshospitalet; and Department of Neurology, Aalborg Hospital, and The Danish MS Treatment Register (Dr. Koch-Henriksen), Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Copenhagen MS Center, Department of Neurology (Dr. Sorensen), and Institute for Inflammation Research (Drs. Ross and Bendtzen), Copenhagen University Hospital, Rigshospitalet; and Department of Neurology, Aalborg Hospital, and The Danish MS Treatment Register (Dr. Koch-Henriksen), Denmark","institution_ids":["https://openalex.org/I2799976261","https://openalex.org/I2802567020","https://openalex.org/I2802709434"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025641135","display_name":"Nils Koch\u2010Henriksen","orcid":"https://orcid.org/0000-0001-7985-7573","observed_orcids":["https://orcid.org/0000-0001-7985-7573"]},"institutions":[{"id":"https://openalex.org/I2799976261","display_name":"Aalborg University Hospital","ror":"https://ror.org/02jk5qe80","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2799976261"]},{"id":"https://openalex.org/I2802567020","display_name":"Copenhagen University Hospital","ror":"https://ror.org/05bpbnx46","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802567020"]},{"id":"https://openalex.org/I2802709434","display_name":"Rigshospitalet","ror":"https://ror.org/03mchdq19","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802567020","https://openalex.org/I2802709434","https://openalex.org/I4210145385"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"N. Koch-Henriksen","raw_affiliation_strings":["From the Copenhagen MS Center, Department of Neurology (Dr. Sorensen), and Institute for Inflammation Research (Drs. Ross and Bendtzen), Copenhagen University Hospital, Rigshospitalet; and Department of Neurology, Aalborg Hospital, and The Danish MS Treatment Register (Dr. Koch-Henriksen), Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Copenhagen MS Center, Department of Neurology (Dr. Sorensen), and Institute for Inflammation Research (Drs. Ross and Bendtzen), Copenhagen University Hospital, Rigshospitalet; and Department of Neurology, Aalborg Hospital, and The Danish MS Treatment Register (Dr. Koch-Henriksen), Denmark","institution_ids":["https://openalex.org/I2799976261","https://openalex.org/I2802567020","https://openalex.org/I2802709434"]}]},{"author_position":"middle","author":{"id":null,"display_name":"C. Ross","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799976261","display_name":"Aalborg University Hospital","ror":"https://ror.org/02jk5qe80","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2799976261"]},{"id":"https://openalex.org/I2802567020","display_name":"Copenhagen University Hospital","ror":"https://ror.org/05bpbnx46","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802567020"]},{"id":"https://openalex.org/I2802709434","display_name":"Rigshospitalet","ror":"https://ror.org/03mchdq19","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802567020","https://openalex.org/I2802709434","https://openalex.org/I4210145385"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"C. Ross","raw_affiliation_strings":["From the Copenhagen MS Center, Department of Neurology (Dr. Sorensen), and Institute for Inflammation Research (Drs. Ross and Bendtzen), Copenhagen University Hospital, Rigshospitalet; and Department of Neurology, Aalborg Hospital, and The Danish MS Treatment Register (Dr. Koch-Henriksen), Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Copenhagen MS Center, Department of Neurology (Dr. Sorensen), and Institute for Inflammation Research (Drs. Ross and Bendtzen), Copenhagen University Hospital, Rigshospitalet; and Department of Neurology, Aalborg Hospital, and The Danish MS Treatment Register (Dr. Koch-Henriksen), Denmark","institution_ids":["https://openalex.org/I2799976261","https://openalex.org/I2802567020","https://openalex.org/I2802709434"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004422882","display_name":"Katja Maria Clemmesen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799976261","display_name":"Aalborg University Hospital","ror":"https://ror.org/02jk5qe80","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2799976261"]},{"id":"https://openalex.org/I2802567020","display_name":"Copenhagen University Hospital","ror":"https://ror.org/05bpbnx46","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802567020"]},{"id":"https://openalex.org/I2802709434","display_name":"Rigshospitalet","ror":"https://ror.org/03mchdq19","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802567020","https://openalex.org/I2802709434","https://openalex.org/I4210145385"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"K. M. Clemmesen","raw_affiliation_strings":["From the Copenhagen MS Center, Department of Neurology (Dr. Sorensen), and Institute for Inflammation Research (Drs. Ross and Bendtzen), Copenhagen University Hospital, Rigshospitalet; and Department of Neurology, Aalborg Hospital, and The Danish MS Treatment Register (Dr. Koch-Henriksen), Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Copenhagen MS Center, Department of Neurology (Dr. Sorensen), and Institute for Inflammation Research (Drs. Ross and Bendtzen), Copenhagen University Hospital, Rigshospitalet; and Department of Neurology, Aalborg Hospital, and The Danish MS Treatment Register (Dr. Koch-Henriksen), Denmark","institution_ids":["https://openalex.org/I2799976261","https://openalex.org/I2802567020","https://openalex.org/I2802709434"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105789044","display_name":"Klaus Bendtzen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799976261","display_name":"Aalborg University Hospital","ror":"https://ror.org/02jk5qe80","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2799976261"]},{"id":"https://openalex.org/I2802567020","display_name":"Copenhagen University Hospital","ror":"https://ror.org/05bpbnx46","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802567020"]},{"id":"https://openalex.org/I2802709434","display_name":"Rigshospitalet","ror":"https://ror.org/03mchdq19","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802567020","https://openalex.org/I2802709434","https://openalex.org/I4210145385"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"K. Bendtzen","raw_affiliation_strings":["From the Copenhagen MS Center, Department of Neurology (Dr. Sorensen), and Institute for Inflammation Research (Drs. Ross and Bendtzen), Copenhagen University Hospital, Rigshospitalet; and Department of Neurology, Aalborg Hospital, and The Danish MS Treatment Register (Dr. Koch-Henriksen), Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Copenhagen MS Center, Department of Neurology (Dr. Sorensen), and Institute for Inflammation Research (Drs. Ross and Bendtzen), Copenhagen University Hospital, Rigshospitalet; and Department of Neurology, Aalborg Hospital, and The Danish MS Treatment Register (Dr. Koch-Henriksen), Denmark","institution_ids":["https://openalex.org/I2799976261","https://openalex.org/I2802567020","https://openalex.org/I2802709434"]}]},{"author_position":"last","author":{"id":null,"display_name":"the Danish Multiple Sclerosis Study Group","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"the Danish Multiple Sclerosis Study Group","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":16.2535,"has_fulltext":false,"cited_by_count":201,"citation_normalized_percentile":{"value":0.99593006,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"65","issue":"1","first_page":"33","last_page":"39"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neutralizing-antibodies","display_name":"neutralizing antibodies","score":0.9890000224113464},{"id":"https://openalex.org/keywords/interferon-beta","display_name":"interferon-beta","score":0.7760000228881836},{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":0.9909999966621399},{"id":"https://openalex.org/keywords/interferon-beta-1a","display_name":"interferon beta-1a","score":0.8450000286102295},{"id":"https://openalex.org/keywords/interferon-beta-1b","display_name":"interferon beta-1b","score":0.9990000128746033},{"id":"https://openalex.org/keywords/antibody-persistence","display_name":"antibody persistence","score":0.5379999876022339},{"id":"https://openalex.org/keywords/treatment-monitoring","display_name":"treatment monitoring","score":0.6259999871253967},{"id":"https://openalex.org/keywords/avonex","display_name":"Avonex","score":0.5659999847412109},{"id":"https://openalex.org/keywords/rebif","display_name":"Rebif","score":0.824999988079071}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8726991415023804},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.6547502875328064},{"id":"https://openalex.org/C2994247566","wikidata":"https://www.wikidata.org/wiki/Q2450337","display_name":"Interferon beta","level":3,"score":0.6351101398468018},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.62705397605896},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.616619348526001},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5398579835891724},{"id":"https://openalex.org/C2779261636","wikidata":"https://www.wikidata.org/wiki/Q7003054","display_name":"Neutralizing antibody","level":3,"score":0.4425336718559265},{"id":"https://openalex.org/C2776174256","wikidata":"https://www.wikidata.org/wiki/Q830842","display_name":"BETA (programming language)","level":2,"score":0.43232715129852295},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.38949552178382874},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068556","descriptor_name":"Interferon beta-1a","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000068576","descriptor_name":"Interferon beta-1b","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000276","descriptor_name":"Adjuvants, Immunologic","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001323","descriptor_name":"Autoantibodies","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D001323","descriptor_name":"Autoantibodies","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D001681","descriptor_name":"Biological Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003718","descriptor_name":"Denmark","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007118","descriptor_name":"Immunoassay","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009103","descriptor_name":"Multiple Sclerosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009103","descriptor_name":"Multiple Sclerosis","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D009103","descriptor_name":"Multiple Sclerosis","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D012042","descriptor_name":"Registries","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D016899","descriptor_name":"Interferon-beta","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D016899","descriptor_name":"Interferon-beta","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1212/01.wnl.0000166049.51502.6a","doi":"https://doi.org/10.1212/01.wnl.0000166049.51502.6a","is_oa":false,"landing_page_url":"https://doi.org/10.1212/01.wnl.0000166049.51502.6a","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},{"id":"pmid:15888603","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15888603","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"Journal Article"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/fcea2112-5030-4d0e-b833-4c3f0eb4d5b9","doi":null,"is_oa":false,"landing_page_url":"https://researchprofiles.ku.dk/da/publications/fcea2112-5030-4d0e-b833-4c3f0eb4d5b9","pdf_url":null,"source":{"id":"https://openalex.org/S4306401983","display_name":"Research at the University of Copenhagen (University of Copenhagen)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I124055696","host_organization_name":"University of Copenhagen","host_organization_lineage":["https://openalex.org/I124055696"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Sorensen, P S, Koch-Henriksen, N, Ross, C, Clemmesen, K M, Bendtzen, K & Danish Multiple Sclerosis Study Group 2005, 'Appearance and disappearance of neutralizing antibodies during interferon-beta therapy', Neurology, vol. 65, no. 1, pp. 33-9. https://doi.org/10.1212/01.WNL.0000166049.51502.6A","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.atira.dk:publications/300a11c0-bfd0-11da-bee9-02004c4f4f50","doi":null,"is_oa":false,"landing_page_url":"https://pure.au.dk/portal/en/publications/300a11c0-bfd0-11da-bee9-02004c4f4f50","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"S\u00f8rensen, P S, Koch-Henriksen, N, Ross, C, Clemmesen, K M, Bendtzen, K, Petersen, T & Danish Multiple Sclerosis Study Group 2005, 'Appearance and disappearance of neutralizing antibodies during interferon-beta therapy', Neurology, vol. 65, no. 1, pp. 33-39.","raw_type":"info:eu-repo/semantics/publishedVersion"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":34,"referenced_works":["https://openalex.org/W1574435394","https://openalex.org/W1578501621","https://openalex.org/W1966221405","https://openalex.org/W1969339244","https://openalex.org/W1975995030","https://openalex.org/W1983855969","https://openalex.org/W1987692041","https://openalex.org/W2014108934","https://openalex.org/W2015730831","https://openalex.org/W2019315255","https://openalex.org/W2029224047","https://openalex.org/W2031424185","https://openalex.org/W2035167238","https://openalex.org/W2046354075","https://openalex.org/W2050447183","https://openalex.org/W2053024796","https://openalex.org/W2054547390","https://openalex.org/W2096569053","https://openalex.org/W2097669496","https://openalex.org/W2104692290","https://openalex.org/W2110233110","https://openalex.org/W2110466329","https://openalex.org/W2120389810","https://openalex.org/W2139367012","https://openalex.org/W2164542304","https://openalex.org/W2168301183","https://openalex.org/W2168428527","https://openalex.org/W2169098250","https://openalex.org/W2175739361","https://openalex.org/W2485483395","https://openalex.org/W2509277703","https://openalex.org/W4210548604","https://openalex.org/W4234254101","https://openalex.org/W4243515193"],"related_works":["https://openalex.org/W2123570781","https://openalex.org/W2041142866","https://openalex.org/W2135277259","https://openalex.org/W2120389810","https://openalex.org/W2110466329","https://openalex.org/W2796063461","https://openalex.org/W2079043571","https://openalex.org/W1992829415","https://openalex.org/W2095416682","https://openalex.org/W2131960841"],"abstract_inverted_index":{"BACKGROUND:":[0],"Neutralizing":[1],"antibodies":[2],"(NABs)":[3],"occur":[4],"frequently":[5],"in":[6,53,121,206],"patients":[7,54,81,95,106,118,128,143,208,213],"receiving":[8],"interferon":[9],"(IFN)-beta":[10],"for":[11,25,60,218,230,241],"multiple":[12],"sclerosis":[13],"(MS),":[14],"but":[15],"it":[16],"is":[17,23],"unclear":[18],"whether":[19],"occurrence":[20],"of":[21,28,116,126,174,184,197,233],"NABs":[22,29,44,202],"predictive":[24],"the":[26,122,127,137,170,180,182],"persistence":[27],"during":[30,65,169],"continued":[31],"IFN-beta":[32],"therapy.":[33],"METHODS:":[34],"The":[35],"authors":[36],"used":[37],"an":[38],"antiviral":[39],"neutralization":[40],"bioassay":[41],"to":[42,50],"measure":[43],"blindly":[45],"from":[46,190],"6":[47],"months":[48,52,64,173,194,235],"up":[49],"78":[51],"with":[55,67,107,145,210],"MS":[56],"who":[57,96,165,186,226],"were":[58,70,119,129,140],"followed":[59],"at":[61,86,98],"least":[62,99],"24":[63,172,219],"treatment":[66],"IFN-beta.":[68,211],"Patients":[69,164,225],"classified":[71],"into":[72],"three":[73],"groups:":[74],"1)":[75],"persistently":[76,130,216],"NAB-negative":[77,111,149,168,217],"patients,":[78,92,185],"defined":[79,93],"as":[80,94],"without":[82],"any":[83,87],"positive":[84,102],"samples":[85],"time;":[88],"2)":[89],"definitely":[90,134],"NAB-positive":[91,109,189,229,240],"had":[97,187],"two":[100],"consecutive":[101],"samples;":[103],"and":[104,110,136,161],"3)":[105],"fluctuating":[108],"samples.":[112],"RESULTS:":[113],"A":[114],"total":[115],"455":[117],"included":[120],"study.":[123],"Overall,":[124],"52.3%":[125],"NAB-negative,":[131],"40.9%":[132],"became":[133],"NAB-positive,":[135],"remaining":[138],"6.8%":[139],"fluctuating.":[141],"More":[142],"treated":[144,209],"IFN-beta-1a":[146,162],"(Avonex)":[147],"remained":[148,167,199],"(p":[150],"<":[151],"0.0001),":[152],"whereas":[153],"there":[154],"was":[155],"no":[156],"difference":[157],"between":[158],"IFN-beta-1b":[159],"(Betaferon)":[160],"(Rebif).":[163],"have":[166,214,227],"first":[171],"therapy":[175],"rarely":[176],"developed":[177],"NABs.":[178],"On":[179],"contrary,":[181],"majority":[183],"been":[188,215,228],"12":[191],"through":[192],"30":[193],"after":[195],"start":[196],"therapy,":[198],"NAB-positive.":[200],"CONCLUSIONS:":[201],"should":[203],"be":[204,223],"measured":[205],"all":[207],"If":[212],"months,":[220],"measurements":[221],"can":[222],"discontinued.":[224],"a":[231,242],"period":[232],"18":[234],"or":[236],"more":[237],"usually":[238],"remain":[239],"long":[243],"time.":[244]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2129012981","counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":15},{"year":2013,"cited_by_count":11},{"year":2012,"cited_by_count":12}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
